Christmas Appeal 2019

Help bring us closer to a world where all children who are diagnosed with the children's cancer neuroblastoma have the chance to grow up, free from the side effects of their treatments. Read more

Dinutuximab-beta (qarziba) registration update

EUSA Pharma is pursuing registration and funding in Australia for Qarziba (also known as Dinutuximab-beta) an anti-GD2 monoclonal antibody for the treatment of high-risk neuroblastoma patients aged 12 months and over. Read more

Imaging tumor stiffness could aid delivery of treatment to most challenging cancers

A new non-invasive imaging technique that measures the stiffness of tissues providing crucial new information about breast and pancreatic cancer architecture and could aid the delivery of treatment to the most challenging tumours. Read more

Tassie devils hold clue how human cancers evade immune system

Melbourne researchers from Peter MacCallum Cancer Centre, in collaboration with Cancer Research UK, have uncovered a new way that some human cancers can hide from the body’s immune system. Read more

Research Grants Closing Soon

Applicants have until 30 September 2019 to submit their proposal and grant applications of up to $125,000 will be considered by Neuroblastoma Australia. Read more

Spotlight on Dr Christina Signorelli

Meet one of our 2019 Neuroblastoma Australia Grant Recipients, Dr Signorelli and learn of her passion for improving the long-term health of Australian childhood cancer survivors. Read more

Our Christmas gift range has arrived!

Have you checked out our neuroblastoma australia shop? We have a new range of Christmas cards and toys including the sparkly bashful bunny! Purchase a gift for someone you love, that also gives back. Read more